Slow fluctuations of single unit activities of hippocampal and thalamic neurons in cats. II. Role of serotonin on the stability of neuronal activities.
T Kodama, H Mushiake, K Shima, T Hayashi, M Yamamoto
Brain Research May 1, 1989 DOI: 10.1016/0006-8993(89)90937-2 (opens in new tab)
Study at a glance
AI-extracted from the abstract| Characteristics | Experimental animal study (single-unit electrophysiology) Peer reviewed |
|---|---|
| Population | Cats (hippocampal pyramidal and thalamic ventrobasal neurons) |
| Intervention | 5-methoxy-N |
| Topics | Serotonin |
| Keywords | Hippocampus Thalamus Animals Cats Methoxydimethyltryptamines Fenclonine Action potentials |
| Key findings | Serotonin depletion with PCPA produced prominent slow fluctuations (0.02–1.0 Hz) in hippocampal and thalamic neuronal activity similar to paradoxical sleep, while subsequent 5-MeO-DMT administration suppressed these fluctuations and yielded activity resembling slow-wave sleep. The authors conclude that brain serotonin plays a role in stabilizing single neuronal activity. |
Abstract
A series of experiments was carried out both in the hippocampal pyramidal and thalamic ventrobasal neurons to investigate the effect of serotonin level in the brain on slow fluctuations of neuronal discharges. Single neuronal activities were recorded in the following two pharmacologically treated states: (1) a 5-hydroxytryptamine depleted state by p-chlorophenylalanine administration (PCPA phase) and (2) a 5-methoxy-N,N-dimethyltryptamine administered state under the PCPA pretreatment (5-MeODMT phase). The slow fluctuations of neuronal activities in the frequency range of 0.02-1.0 Hz in both nuclei were prominent during the PCPA phase and were similar to those during the paradoxical sleep. In contrast, slow fluctuations were suppressed during the 5-MeODMT phase and neuronal activities during this phase were similar to those during slow wave sleep (SWS). The results show that serotonin in the brain definitely plays a role in stabilizing single neuronal activities.
Comparable studies
Other preclinical and animal studies on serotonin, most cited first.
| Study | Year | Design | Participants |
|---|---|---|---|
| Psilocybin induces rapid and persistent growth of dendritic spines in frontal cortex in vivo Mice | 2021 | Observational cohort | |
| Neurotoxicity of the psychedelic amphetamine, methylenedioxymethamphetamine. Rats (implied by typical neurochemical study context) | 1987 | Experimental study | |
| Psychedelics promote neuroplasticity through the activation of intracellular 5-HT2A receptors In vitro and in vivo (rodent) models | 2023 | Experimental study | |
| 3,4-Methylenedioxymethamphetamine and 3,4-methylenedioxyamphetamine destroy serotonin terminals in rat brain: quantification of neurodegeneration by measurement of [3H]paroxetine-labeled serotonin uptake sites. Rat brain | 1987 | Animal experiment | |
| Comparison of the monoamine transporters from human and mouse in their sensitivities to psychostimulant drugs Human and mouse dopamine, norepinephrine, and serotonin transporters expressed in cells | 2006 | In vitro laboratory study |